416 related articles for article (PubMed ID: 16945016)
1. Rb+ efflux through functional activation of cardiac KCNQ1/minK channels by the benzodiazepine R-L3 (L-364,373).
Jow F; Tseng E; Maddox T; Shen R; Kowal D; Dunlop J; Mekonnen B; Wang K
Assay Drug Dev Technol; 2006 Aug; 4(4):443-50. PubMed ID: 16945016
[TBL] [Abstract][Full Text] [Related]
2. Validation of an atomic absorption rubidium ion efflux assay for KCNQ/M-channels using the ion Channel Reader 8000.
Wang K; McIlvain B; Tseng E; Kowal D; Jow F; Shen R; Zhang H; Shan QJ; He L; Chen D; Lu Q; Dunlop J
Assay Drug Dev Technol; 2004 Oct; 2(5):525-34. PubMed ID: 15671650
[TBL] [Abstract][Full Text] [Related]
3. Calmodulin is essential for cardiac IKS channel gating and assembly: impaired function in long-QT mutations.
Shamgar L; Ma L; Schmitt N; Haitin Y; Peretz A; Wiener R; Hirsch J; Pongs O; Attali B
Circ Res; 2006 Apr; 98(8):1055-63. PubMed ID: 16556865
[TBL] [Abstract][Full Text] [Related]
4. Long QT syndrome-associated mutations in KCNQ1 and KCNE1 subunits disrupt normal endosomal recycling of IKs channels.
Seebohm G; Strutz-Seebohm N; Ureche ON; Henrion U; Baltaev R; Mack AF; Korniychuk G; Steinke K; Tapken D; Pfeufer A; Kääb S; Bucci C; Attali B; Merot J; Tavare JM; Hoppe UC; Sanguinetti MC; Lang F
Circ Res; 2008 Dec; 103(12):1451-7. PubMed ID: 19008479
[TBL] [Abstract][Full Text] [Related]
5. Chronic probucol treatment decreases the slow component of the delayed-rectifier potassium current in CHO cells transfected with KCNQ1 and KCNE1: a novel mechanism of QT prolongation.
Taniguchi T; Uesugi M; Arai T; Yoshinaga T; Miyamoto N; Sawada K
J Cardiovasc Pharmacol; 2012 Apr; 59(4):377-86. PubMed ID: 22189896
[TBL] [Abstract][Full Text] [Related]
6. A novel benzodiazepine that activates cardiac slow delayed rectifier K+ currents.
Salata JJ; Jurkiewicz NK; Wang J; Evans BE; Orme HT; Sanguinetti MC
Mol Pharmacol; 1998 Jul; 54(1):220-30. PubMed ID: 9658209
[TBL] [Abstract][Full Text] [Related]
7. Insights into Cardiac IKs (KCNQ1/KCNE1) Channels Regulation.
Wu X; Larsson HP
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322401
[TBL] [Abstract][Full Text] [Related]
8. LQT1 mutations in KCNQ1 C-terminus assembly domain suppress IKs using different mechanisms.
Aromolaran AS; Subramanyam P; Chang DD; Kobertz WR; Colecraft HM
Cardiovasc Res; 2014 Dec; 104(3):501-11. PubMed ID: 25344363
[TBL] [Abstract][Full Text] [Related]
9. Action potential clamp and mefloquine sensitivity of recombinant 'I KS' channels incorporating the V307L KCNQ1 mutation.
El Harchi A; McPate MJ; Zhang YH; Zhang H; Hancox JC
J Physiol Pharmacol; 2010 Apr; 61(2):123-31. PubMed ID: 20436212
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological activation of normal and arrhythmia-associated mutant KCNQ1 potassium channels.
Seebohm G; Pusch M; Chen J; Sanguinetti MC
Circ Res; 2003 Nov; 93(10):941-7. PubMed ID: 14576198
[TBL] [Abstract][Full Text] [Related]
11. Tight coupling of rubidium conductance and inactivation in human KCNQ1 potassium channels.
Seebohm G; Sanguinetti MC; Pusch M
J Physiol; 2003 Oct; 552(Pt 2):369-78. PubMed ID: 14561821
[TBL] [Abstract][Full Text] [Related]
12. Transcripts of Kv7.1 and MinK channels and slow delayed rectifier K
Abramochkin DV; Hassinen M; Vornanen M
Pflugers Arch; 2018 Dec; 470(12):1753-1764. PubMed ID: 30116893
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological rescue of specific long QT variants of KCNQ1/KCNE1 channels.
Zou X; Wu X; Sampson KJ; Colecraft HM; Larsson HP; Kass RS
Front Physiol; 2022; 13():902224. PubMed ID: 36505078
[TBL] [Abstract][Full Text] [Related]
14. Biophysical characteristics of a new mutation on the KCNQ1 potassium channel (L251P) causing long QT syndrome.
Deschênes D; Acharfi S; Pouliot V; Hegele R; Krahn A; Daleau P; Chahine M
Can J Physiol Pharmacol; 2003 Feb; 81(2):129-34. PubMed ID: 12710526
[TBL] [Abstract][Full Text] [Related]
15. Dysfunctional potassium channel subunit interaction as a novel mechanism of long QT syndrome.
Hoosien M; Ahearn ME; Myerburg RJ; Pham TV; Miller TE; Smets MJ; Baumbach-Reardon L; Young ML; Farooq A; Bishopric NH
Heart Rhythm; 2013 May; 10(5):728-37. PubMed ID: 23291057
[TBL] [Abstract][Full Text] [Related]
16. Allosteric mechanism for KCNE1 modulation of KCNQ1 potassium channel activation.
Kuenze G; Vanoye CG; Desai RR; Adusumilli S; Brewer KR; Woods H; McDonald EF; Sanders CR; George AL; Meiler J
Elife; 2020 Oct; 9():. PubMed ID: 33095155
[TBL] [Abstract][Full Text] [Related]
17. Adult KCNE1-knockout mice exhibit a mild cardiac cellular phenotype.
Charpentier F; Merot J; Riochet D; Le Marec H; Escande D
Biochem Biophys Res Commun; 1998 Oct; 251(3):806-10. PubMed ID: 9790991
[TBL] [Abstract][Full Text] [Related]
18. KCNE1 reverses the response of the human K+ channel KCNQ1 to cytosolic pH changes and alters its pharmacology and sensitivity to temperature.
Unsöld B; Kerst G; Brousos H; Hübner M; Schreiber R; Nitschke R; Greger R; Bleich M
Pflugers Arch; 2000 Dec; 441(2-3):368-78. PubMed ID: 11211125
[TBL] [Abstract][Full Text] [Related]
19. Effect of Channel Assembly (KCNQ1 or KCNQ1 + KCNE1) on the Response of Zebrafish IKs Current to IKs Inhibitors and Activators.
Haverinen J; Hassinen M; Vornanen M
J Cardiovasc Pharmacol; 2022 May; 79(5):670-677. PubMed ID: 35377576
[TBL] [Abstract][Full Text] [Related]
20. Gating and flickery block differentially affected by rubidium in homomeric KCNQ1 and heteromeric KCNQ1/KCNE1 potassium channels.
Pusch M; Bertorello L; Conti F
Biophys J; 2000 Jan; 78(1):211-26. PubMed ID: 10620287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
